Trials
Search / Trial NCT05647525

The Etiology of New-onset Status Epilepticus

Launched by JIE LIU · Dec 4, 2022

Trial Information

Current as of January 21, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of Status Epilepticus
  • Sign the informed consent form
  • Exclusion Criteria:
  • Patients with previous epilepsy
  • Missing information such as basic information and treatment history
  • Long-term smoking, alcohol and drug abuse
  • Pregnant and breastfeeding women

About Jie Liu

Jie Liu is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutics and enhancing patient care, Jie Liu collaborates with a network of leading researchers and institutions to design, implement, and manage clinical trials across various therapeutic areas. Emphasizing scientific rigor and ethical standards, Jie Liu strives to contribute to the understanding of diseases and the development of effective treatment modalities, ultimately aiming to improve health outcomes for diverse patient populations.

Locations

Chengdu, Sichuan, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials